NDAINHALATIONGAS
Approved
Jun 2022
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
2/8 — Basic
Drug data last refreshed 2d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OXYGEN, USP is a gas-form inhalation therapy approved in June 2022 for treating respiratory failure, COPD, hypoxia, ARDS, and COVID-19. It is a foundational therapeutic gas with no traditional mechanism of action classification, functioning as a life-sustaining respiratory support agent. The product addresses critical hypoxemic conditions across acute and chronic care settings.
Peak
Peak-lifecycle product with moderate competitive pressure (30%) suggests stable revenue streams and established market positioning, though team expansion may be limited.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Safety Study of Intravenous Hydrogen-Oxygen Ultrafine Bubbles in Adults
Started May 2026
50 enrolled
Healthy Volunteer
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
Started Apr 2026
39 enrolled
Bronchopulmonary DysplasiaPulmonary Hypertension
Endoscopic COlorectal Mucosal Evaluation of Oxygen Tension
Started Apr 2026
80 enrolled
Anastomotic Leak RectumAnastomotic Leak Large Intestine
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
Started Dec 2025
Normobaric Oxygen Therapy in Colorectal Cancer Patients
Started Nov 2025
254 enrolled
Colorectal Cancer (CRC)
Worked on OXYGEN, USP at Universal Cells? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.